Severity
Moderate
FDA Drug recall · Reported June 22, 2022
Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims.
Walmart Inc recalled Artri Ajo King Reforzado con Ortiga y Omega 3 Tablets, ORIGINAL, 100-count bottles, UPC 7… - a moderate-severity action.
Artri Ajo King Reforzado con Ortiga y Omega 3 Tablets, ORIGINAL, 100-count bottles, UPC 7… was recalled by Walmart Inc in June 22, 2022. Reason: Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims.. Check the official notice for the remedy. Verify recall #D-1158-2022 with the FDA Drug before acting.
The recall
Walmart Inc issued this moderate-severity FDA Drug recall-Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims..
Sourced from official FDA Drug enforcement records. Verify recall #D-1158-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1158-2022) was formally reported on June 22, 2022, with the manufacturer initiating the action on May 24, 2022. It is classified under Moderate severity (Class II), with a current status of Completed. Walmart Inc is listed as the recalling firm, operating out of Bentonville, AR. Federal records list the affected scope as 1308 bottles total.
The documented reason for this recall is: Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims. Distribution data in the federal record shows the product reached: Nationwide in the USA.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 2,002 dietary supplements recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
1308 bottles total
Related Recalls
6
0 from same agency
Artri Ajo King Reforzado con Ortiga y Omega 3 Tablets, ORIGINAL, 100-count bottles, UPC 7 501031 12705.
Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Completed |
| Recall number | D-1158-2022 |
| Date reported | June 22, 2022 |
| Date initiated | May 24, 2022 |
| Recalling firm | Walmart Inc |
| Firm location | Bentonville, AR |
| Affected scope | 1308 bottles total |
| Distribution | Nationwide in the USA. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Pure Vitamins and Natural Supplements, LLC · 2026-04-15
Pure Vitamins and Natural Supplements, LLC · 2026-04-15
Herbal Creations USA · 2026-04-01
Winder Laboratories, LLC · 2026-03-25
Imu-Tek Animal Health, Incorporated · 2026-02-11
Compare this recall with Blue Bull Extreme Male Enhancement Supplement, total of 15 … →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported June 22, 2022. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.